Effects of drugs on ocular muscles.
D000700:Analgesics / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D000963:Antimetabolites / Q000009:adverse effects; D002301:Cardiac Glycosides / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002614:Chelating Agents / Q000009:adverse effects; D002675:Child, Preschool; D004295:Dihydroxyphenylalanine / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007213:Indomethacin / Q000009:adverse effects; D007328:Insulin / Q000009:adverse effects; D009135:Muscular Diseases / Q000139:chemically induced*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects; D009801:Oculomotor Muscles / Q000187:drug effects*; D010276:Parasympatholytics / Q000009:adverse effects; D011041:Poisoning; D014815:Vitamins / Q000009:adverse effects
D000700:Analgesics; D000777:Anesthetics; D000890:Anti-Infective Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D000962:Antimalarials; D000963:Antimetabolites; D002301:Cardiac Glycosides; D000697:Central Nervous System Stimulants; D002614:Chelating Agents; D006213:Hallucinogens; D006993:Hypnotics and Sedatives; D007328:Insulin; D003473:Neuromuscular Nondepolarizing Agents; D010276:Parasympatholytics; D014815:Vitamins; D004295:Dihydroxyphenylalanine; D007213:Indomethacin